Current Clinical Trials
There are no current clinical trials as of January 2018.
Upcoming Clinical Trials
Canine Osteosarcoma Vaccine, Live Listeria Vector (COV-LLV) – Upcoming Spring 2018
Starting this Spring 2018, our Culver City office will be participating in a study to evaluate the Canine Osteosarcoma Vaccine, Live Listeria Vector (COV-LLV), a conditionally licensed product for dogs with osteosarcoma who have undergone amputation and chemotherapy. For participation, your dog must meet the eligibility requirements listed in the study protocol. Your veterinarian will confirm eligibility by reviewing your dog’s medical history, performing a physical exam, taking thoracic radiographs, and submitting routine blood and urine testing. All dogs enrolled in the study will be treated with the immunotherapy.
Keep checking back for updates as we will post them here. If you have any additional questions, please email us at LA.email@example.com with the subject line "COV-LLV Question" or call our Culver City office at (310) 558-6120 and ask to speak with trial aides, Josef or Melissa.
(Prior to acceptance into any trial, all candidates are required to have a consultation to determine eligibility.
The fee for the consultation is the responsibility of the pet owner.)
Visit this link for more information about current pet clinical trials, visit American Veterinary Medical Association's Animal Health Studies Database.